期刊文献+

多发性乳腺纤维腺瘤患者免疫组化相关指标的研究 被引量:1

The Study on the Relative Immunohistochemical Index in the Patient with Multiple Fibroadenoma of Breast
下载PDF
导出
摘要 目的:探讨多发性乳腺纤维腺瘤的病因和发病机理,研究免疫组化法检测的相关指标在本病发生过程中的意义。方法:用免疫组化法检测90例多发性乳腺纤维腺瘤患者和30例乳腺增生病患者乳腺组织中雌激素受体(estro-gen receptor,ER)、孕激素受体(progesterone receptor,PR)、细胞增殖抗原标记物(Ki-67)、抑癌基因P53及人类癌基因CerbB-2的表达。结果:(1)多发性乳腺纤维腺瘤患者PR的阳性表达率及高强度阳性表达率均高于对照组(前者P<0.01,后者P<0.05);Ki-67的阳性表达率明显高于对照组(P<0.05);(2)多发性乳腺纤维腺瘤患者ER、PR之间有显著相关性(P<0.01);(3)多发性乳腺纤维腺瘤患者ER的阳性表达率与对照组相比无显著性差异(P>0.05);(4)多发性乳腺纤维腺瘤患者ER、PR与Ki-67的表达之间无相关性(P>0.05);(5)P53和CerbB-2在本病中均无表达。结论:(1)局部乳腺组织中PR的阳性表达率及阳性表达强度升高也是乳腺纤维腺瘤发病的主要因素;(2)ER、PR间存在的相关性在本病的发生中起了主要作用;(3)Ki-67的阳性表达率升高,说明细胞增殖能力较强,这可能也是本病发生的直接原因。 Objective:To examine the pathogenesis of multiple fibroadenoma of breast and discuss the significance of immunohistochemical indicatrix in the process of the disease.Methods:The expression of estrogen receptor(ER),progesterone receptor(PR),the cell proliferating antigen Ki-67,anti-oncogene P53 and human oncogene CerbB-2 were tested by the immunohistochemical assay in 90 cases with multiple fibroadenoma of breast and 30 cases with mammary hyperplasia.Results:(1)The positive rate and the powerful positive rate of PR expression were both higher than that in healthy control group significantly(respectively P0.01,P0.05).(2)There was significant dependability between ER and PR in the cases with multiple fibroadenoma of breast(P0.01).(3)There was no significant dependability for the positive rate of ER expression between the cases with multiple fibroadenoma of breast and the control group(P0.05).(4)There was no significant dependablity between the expression of ER and PR and the expression of Ki-67(P 0.05).(5)There was no expression of P53 and CerbB-2 in the cases with multiple fibroadenoma of breast.Conclusion:(1)The increase of the positive rate and the powerful positive rate of PR expression in mammary gland partly is the major factor for the multiple fibroadenoma of breast.(2)The dependability between ER and PR make an important role in the disease.(3)The increase of the positive rate of Ki-67 expression prove that the cells' reproductive activity is strong,and perhaps this is the immediate cause which induce the disease.
出处 《医学理论与实践》 2011年第10期1117-1120,共4页 The Journal of Medical Theory and Practice
关键词 多发性纤维腺瘤 乳腺肿瘤 免疫组织化学 Multiple fibroadenoma Breast tumor Immunohistochemical
  • 相关文献

参考文献6

二级参考文献21

  • 1陈艺华,蔡俊杰,陆药丹,朱梅刚,李春德.p53蛋白异常表达与乳腺癌淋巴结转移相关性研究[J].中华肿瘤杂志,1994,16(4):266-268. 被引量:26
  • 2吴强 郑国豪 王保太 等.乳腺癌类固醇激素受体的临床病理研究.中华病理学杂志,1989,18(4):247-247.
  • 3Gerdes J, Schwab U, Lemke H, et al. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation [J]. Iht J Cancer, 1983,31 (1):13-20.
  • 4Hall PA, Levison DA, Woods AL, et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms [J]. J Pathol, 1990, 162(4): 285-294.
  • 5Mullerat J, Deroide F, Winslet MC, et al. Proliferation and p53expression in anal cancer precursor lesions [J]. Anticancer Res,2003, 23 (3C): 2995-2999.
  • 6Liu M, Lawson G, Delos M, et al. Predictive value of the fraction of cancer cells immunolabeled for proliferating cell nuclear antigen or Ki67 in biopsies of head and neck carcinomas to identify lymph node metastasis: comparison with clinical and radiologic examinations [J]. Head Neck,2003,25(4): 280-288.
  • 7Tut VM, Braithwaite AL, Angus B, et al. Gyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53,wafl, pRb and Ki67 [J]. Br J Gancer,2001, 84(2): 270-275.
  • 8Bhatavdekar JM, Patel DD, Shah NG,et al. Prognostic significance of immunohisto-chemically localized biomarkers in stage Ⅱ and stage Ⅲ breast cancer: a multivariate analysis [J] . Ann Surg Oncol,2000, 7 (4): 305-311.
  • 9Vincent-Salomon A, Rousseau A, Jouve M, et al. Proliferation markers predictive of the pathological response and disease outcome of patients with breast carcinomas treated by anthracycline-based preoperative chemotherapy [J]. Eur J Cancer,2004(40): 1502-1508.
  • 10Nakopoulou L, Stefanaki K, Panayotopoulou E, et al. Expression of the vascular endothelial growth factor receptor-2/Flk-1 in breast carcinomas: correlation with proliferation [J]. Hum Pathol,2002,33(9): 863-870.

共引文献133

同被引文献12

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部